XML 38 R25.htm IDEA: XBRL DOCUMENT v3.25.1
IPO and Restructuring (Details) - USD ($)
3 Months Ended
Mar. 10, 2025
Mar. 07, 2025
Feb. 14, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
IPO and Restructuring [Line Items]            
Shares of common stock   1,250,000        
Public offering price (in Dollars per share)     $ 4      
Net proceeds (in Dollars)       $ 199,000  
Amount paid (in Dollars) $ 200,000          
Percentage of shares outstanding       96.00%    
Issuance shares       3,782,641    
Restructuring amount       77.30%    
Aggregate principal amount (in Dollars)       $ 1,006,377    
Common stock authorized       50,000,000   200,000
Warrants [Member]            
IPO and Restructuring [Line Items]            
Outstanding warrants       1,125    
Brookstone Partners IAC [Member]            
IPO and Restructuring [Line Items]            
Amount paid (in Dollars) $ 200,000          
BPA XIV, LLC [Member]            
IPO and Restructuring [Line Items]            
Restructuring amount       64.00%    
BP Peptides, LLC [Member]            
IPO and Restructuring [Line Items]            
Restructuring amount       3.00%    
Underwriting discounts [Member]            
IPO and Restructuring [Line Items]            
Net proceeds (in Dollars)     $ 3,252,000      
Common Stock [Member]            
IPO and Restructuring [Line Items]            
Interests exchanged amount       3,782,641    
Common stock authorized       50,000,000    
Preferred Stock [Member]            
IPO and Restructuring [Line Items]            
Peferred stock       25,000,000